| Tag | Content |
|---|
EnhancerAtlas ID | HS105-56567 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chr3:101592130-101592850 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| FOXP1 | MA0481.2 | chr3:101592621-101592633 | ATGTAAACAGAA | + | 6.92 | | FOXP2 | MA0593.1 | chr3:101592621-101592632 | ATGTAAACAGA | + | 6.02 | | NFAT5 | MA0606.1 | chr3:101592518-101592528 | ATTTTCCATT | + | 6.02 | | NFATC1 | MA0624.1 | chr3:101592518-101592528 | ATTTTCCATT | + | 6.02 | | NFATC3 | MA0625.1 | chr3:101592518-101592528 | ATTTTCCATT | + | 6.02 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_09392 | chr3:101591738-101593533 | CD14 | | SE_59234 | chr3:101526313-101596096 | Ly3 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr3 | 101592355 | 101592794 | | chr3 | 101592400 | 101592632 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH03I101873 | chr3 | 101592355 | 101592845 |
|
Enhancer Sequence | TACTTGTCTC TGCACTAACA CTTCTCTATA CTTACTATAA GACCCGGGTA GTCTTGACAT 60
GGGCACGTGC ACCTTAGCCC TGAGTCAAGA ATTCATAGAG AATCTTCCAT ACAACTTCTG 120
GGACCCACCT TCTCACCACC CCCAAAACAC CTTTCGTTTT GGTGCCTTGC TCTACAGATT 180
CTTCTGAACT CTTATCTCTG CCTTGTCAGC TCAGCAGAAC TACTGTGCTC AGATTGGATT 240
CTAGCTTGCT ATGCTGTGGT TGGAAAATTG TACCCTTGCA GAGATCCAGG ATAATCATGG 300
GCCTCACCTA ATGAATTTCT CCTCTCTCAG AGATCACAGT GTTTAATTTC CTGTTGTCCA 360
ATGCTGAAAA ACAATTGCCT CATATATTAT TTTCCATTTC ATTGTTTATG GGTGGAGAGC 420
TAGTCCTATA CCAGTTGTTT CATCATAGTT GGAAGTGAAA GTTTGCAAGA TGTGTTCTTA 480
AAGATTAAAT TATGTAAACA GAAACGGATT TACCAAAGAG GGGGCCCAAA GATTCTGTTT 540
GGGCTGAAAA AGCATTTATA ATAGTCATGA GTCCCATCCT ATGACTCAGA CACTGACTCC 600
ATTCATAGGA AGTTAGTATA GTGGAGTAGA GTGTAGTTTC TCTGCGTTAT TTCTAAAAAT 660
TGAGTCTAAC AGCCATCTCC CCTCTCTAGG AAACAAAAAG AAGGTTTCTA AAAATAATAG 720
|
